Obesity Nutritional, Metabolic, Endocrine Obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged 18-70 2. BMI 30+ 3. Access to a mobile telephone and the internet 4. Actively trying to lose weight
Exclusion criteria
Exclusion criteria: 1. Previous bariatric surgery 2. Terminal illness 3. Dementia 4. Pregnancy 5. Poor competence in English (resulting in an ability to complete study materials) 6. Being a nominated helper in this trial 7. We will ask women of childbearing age to let us know if they become pregnant at any point during the trial. Once recruited, pregnant women will not be excluded from the study but will be given a leaflet on diet and exercising safely during pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stage 1: 1. Acceptability and feasibility will be collected using interviews and focus groups. Stage 2: 1. Physical activity will be measured at baseline and at 12 months using the 7-Day Physical Activity Recall and an accelerometer. 2. Diet will be measured at baseline and at 12 months using the DINE questionnaire and 4x repeat 24 hour multiple pass recall. 3. BMI will be measured at baseline and at 12 months using height and weight measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Waist circumference will be measured at baseline and at 12 months 2. Social support will be measured at baseline and at 12 months using Exercise & Eating Habits Social Support Scales 3. Self efficacy will be measured at baseline and at 12 months using Weight & Exercise Efficacy Lifestyle Scales. 4. Motivation will be measured at baseline and 12 months using the Treatment Self Regulation Questionnaire. 5. Mental health will be measured at baseline and at 12 months using the GHQ12 questionnaire. 6. Health-related quality of life will be measured at baseline and at 12 months using 7. Blood pressure will be measured at baseline and 12 months. 8. Cholesterol will be measured at baseline and 12 months using using a validated non-invasive point-of-care test (Cholestech LDX). 9. Use of NHS and participant borne costs will be measured at baseline and 12 months. 10. Participant and helper experiences of the intervention will be measured at 12 months. | — |
Countries
United Kingdom